Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

In September, Replit completed a $250M funding round that gave it a $3B valuation. That round was led by Prysm Capital and ...

This approach allows developers to create applications through natural language conversations rather than traditional ...

Let's talk about that graveyard of old phones you've got stashed in a kitchen drawer. Instead of letting them collect dust until they're literal ancient artifacts, it's time to put one of those bricks ...

January 19, 2026 • Minnesota braces for federal troops amid immigration protests. And, Trump asks nations to buy into a new U.S.-led board of peace to manage Gaza and other world conflicts.